Regulation of IL-6 signaling by p53: STAT3- and STAT5-masking in p53-Val135-containing human hepatoma Hep3B cell lines - PubMed (original) (raw)

. 1998 Jul 1;161(1):325-34.

Affiliations

PMID: 9647240

Regulation of IL-6 signaling by p53: STAT3- and STAT5-masking in p53-Val135-containing human hepatoma Hep3B cell lines

R J Rayanade et al. J Immunol. 1998.

Abstract

The influence of p53 on cytokine-triggered Janus kinase-STAT signaling was investigated in human hepatoma Hep3B cell lines engineered to constitutively express the temperature-sensitive Val135 mutant of p53. In comparison to the parental p53-free Hep3B cells, these p53-Val135-containing Hep3B cell lines displayed a reduced response to IL-6 at the wild-type-like p53 temperature (32.5 degrees C). In these cells, IL-6 induced a marked reduction in the immunologic accessibility of cytoplasmic and nuclear STAT3 and STAT5 within 20 to 30 min that lasted 2 to 4 h (STAT-masking) provided that the cells had been previously cultured at 32.5 degrees C for at least 18 to 20 h. The onset of IL-6-induced STAT-masking required protein tyrosine kinase, protein tyrosine phosphatase, proteasomal, phospholipase C, and mitogen-activated protein kinase kinase 1 activities. The maintenance of IL-6-induced STAT-masking was dependent on continued signaling through the phosphatidylinositol-dependent phospholipase C pathway. Despite a reduction in IL-6-induced STAT3 DNA binding activity in the nuclear compartment during STAT-masking, there was increased and prolonged accumulation of tyrosine-phosphorylated STAT3 in both the cytoplasmic and nuclear compartments, indicating that the capacity of tyrosine-phosphorylated STAT3 to bind DNA was reduced during STAT-masking. Thus, IL-6-induced STAT-masking, as dramatically evident on immunomicroscopy, is a visible consequence of a novel cellular process by which a p53-Val135-induced gene product(s) regulates the association of masking protein(s) with and the DNA-binding capacity of STAT3.

PubMed Disclaimer

Cited by

Biomolecular condensates in cancer cell biology: interleukin-6-induced cytoplasmic and nuclear STAT3/PY-STAT3 condensates in hepatoma cells.
Sehgal PB. Sehgal PB. Contemp Oncol (Pozn). 2019;23(1):16-22. doi: 10.5114/wo.2019.83018. Epub 2019 Feb 26. Contemp Oncol (Pozn). 2019. PMID: 31061632 Free PMC article.
An ALPHA7 Nicotinic Acetylcholine Receptor Agonist (GTS-21) Promotes C2C12 Myonuclear Accretion in Association with Release of Interleukin-6 (IL-6) and Improves Survival in Burned Mice.
Khan MAS, Khan MF, Kashiwagi S, Kem WR, Yasuhara S, Kaneki M, Tompkins RG, Martyn JAJ. Khan MAS, et al. Shock. 2017 Aug;48(2):227-235. doi: 10.1097/SHK.0000000000000849. Shock. 2017. PMID: 28282360 Free PMC article.
Role of the JAK/STAT signal transduction pathway in the regulation of gene expression in CNS.
Dell'Albani P, Santangelo R, Torrisi L, Nicoletti VG, Giuffrida Stella AM. Dell'Albani P, et al. Neurochem Res. 2003 Jan;28(1):53-64. doi: 10.1023/a:1021644027850. Neurochem Res. 2003. PMID: 12587663 Review.
Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signaling.
Teague TK, Schaefer BC, Hildeman D, Bender J, Mitchell T, Kappler JW, Marrack P. Teague TK, et al. J Exp Med. 2000 Mar 20;191(6):915-26. doi: 10.1084/jem.191.6.915. J Exp Med. 2000. PMID: 10727454 Free PMC article.

Regulation of IL-6 signaling by p53: STAT3- and STAT5-masking in p53-Val135-containing human hepatoma Hep3B cell lines - PubMed (original) (raw)